Investigación

Leucemia y hemopatías pediátricas

Buscador de publicaciones

Publicaciones

  • Parisi C, Candela-Cantó SA, Serrano M, Català-Temprano A, Aparicio J and Hinojosa J.

    Life-threatening secondary hemophagocytic lymphohistiocytosis following vagal nerve stimulator infection in a child with CHD2 myoclonic encephalopathy: a case report

    CHILDS NERVOUS SYSTEM . 36(11): 2851-2856. Nº de citas: 3

    [doi:10.1007/s00381-020-04558-x]

  • Borràs N, Garcia-Martínez I, Batlle J, Pérez-Rodríguez A, Parra R, Altisent C, López-Fernández MF, Costa Pinto J, Batlle-López F, Cid AR, Bonanad S, Cabrera N, Moret A, Mingot-Castellano ME, Navarro N, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández-Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés-Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Del Mar Nieto M, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Corrales I and Vidal F.

    Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

    THROMBOSIS AND HAEMOSTASIS . 120(3): 437-448. Nº de citas: 2

    [doi:10.1055/s-0040-1702227]

  • Viñas-Giménez L, Donadeu L, Alsina L, Rincón R, de la Campa EÁ, Esteve-Solé A, Català-Temprano A, Colobran R, de la Cruz X, Sayós J and Martínez-Gallo M.

    Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity

    INTERNATIONAL JOURNAL OF HEMATOLOGY . 111(3): 440-450. Nº de citas: 3

    [doi:10.1007/s12185-019-02796-7]

  • Ramis-Zaldivar JE, Gonzalez-Farre B, Balagué O, Celis-Passini V, Nadeu F, Salmeron-Villalobos J, Andres M, Martin-Guerrero I, Garrido-Pontnou M, Gaafar A, Suñol M, Barcena C, Garcia-Bragado F, Andión M, Azorín D, Astigarraga I, Sagaseta de Ilurdoz M, Sábado C, Gallego S, Verdu-Amorós J, Fernandez-Delgado R, Perez V, Tapia G, Mozos A, Torrent M, Solano-Páez P, Rivas-Delgado A, Dlouhy I, Clot G, Enjuanes A, López-Guillermo A, Galera PK, Oberley MJ, Maguire A, Ramsower C, Rimsza LM, Quintanilla-Martinez L, Jaffe ES, ELENA CAMPO and Salaverria I.

    Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood . 135(4): 274-286. Nº de citas: 93

    [doi:10.1182/blood.2019002699]

  • Zanetti SR, Romecin PA, Vinyoles M, Juan-Otero M, Fuster JL, Camós-Guijosa M, Querol S, Delgado M and Menendez P.

    Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity

    Journal for ImmunoTherapy of Cancer . 8(2): . Nº de citas: 19

    [doi:10.1136/jitc-2020-001419]

  • Ramírez MJ, Minguillón J, Loveless S, Lake K, Carrasco E, Stjepanovic N, Balmaña J, Català-Temprano A, Mehta PA and Surrallés J.

    Chromosome fragility in the buccal epithelium in patients with Fanconi anemia

    CANCER LETTERS . 472: 1-7. Nº de citas: 12

    [doi:10.1016/j.canlet.2019.12.008]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de citas: 5

    [doi:10.1016/j.phrs.2019.104556]

  • Pérez-Martínez A, Ferreras C, Pascual A, Gonzalez-Vicent M, Alonso L, Badell-Serra I, Navarro JMF, Regueiro A, Plaza M, Hurtado JMP, Benito A, Beléndez C, Couselo JM, Fuster JL, Díaz-Almirón M, Bueno D, Mozo Y, Marsal-Ricoma J, López AG, Sisinni L, de Heredia CD and Díaz MÁ.

    Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).

    AMERICAN JOURNAL OF HEMATOLOGY . 95(1): 28-37. Nº de citas: 31

    [doi:10.1002/ajh.25661]

  • Pérez-Grijalba V, Arbizu J, Romero J, Prieto E, Pesini P, Sarasa L, Guillen F, Monleón I, San-José I, Martínez-Lage P, Munuera-del Cerro JL, Hernández I, Buendía M, Sotolongo-Grau O, Alegret M, Ruiz-Llobet A, Tárraga L, Boada M and Sarasa M.

    Plasma A beta 42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

    ALZHEIMERS RESEARCH & THERAPY . 11(1): 96-96. Nº de citas: 43

    [doi:10.1186/s13195-019-0549-1]

  • Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, De Moerloose B, Davis KL, Nemecek E, Driscoll T, Mechinaud F, Boissel N, Rives-Solà S, Bader P, Peters C, Sabnis HS, Grupp SA, Yanik GA, Hiramatsu H, Stefanski HE, Rasouliyan L, Yi L, Shah S, Zhang J and Harris AC.

    Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial

    LANCET ONCOLOGY . 20(12): 1710-1718. Nº de citas: 65

    [doi:10.1016/S1470-2045(19)30493-0]